Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Genitourinary 2Gastrointestinal 2Other solid neoplasm 1Other 1Head & Neck 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 5Educational Status 4Transcutaneous Electric Nerve Stimulation 2Resistance Training 2Radiotherapy 2Mouthwashes 2Methods 2Megestrol Acetate 2Early Intervention, Educational 2Counseling 2semaglutide 1naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Xylitol 1Weights and Measures 1Vitamin D 1Tablets 1Stents 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Psychiatric Rehabilitation 1Progestins 1Practice Guidelines as Topic 1Population Groups 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Mindfulness 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nutrition Assessment × Other × 90 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡